Place of Origin: | China |
Brand Name: | BeiLi |
Certification: | ISO 9001:2008 |
Model Number: | MBN.99P.N |
Minimum Order Quantity: | unlimited |
---|---|
Price: | negotiation |
Packaging Details: | plastic drum/carton drum/bag/ |
Delivery Time: | 3-10 working days |
Payment Terms: | negotiation |
P/N#: | MBN.99P.N | CAS No: | 1527-89-5 |
---|---|---|---|
Reach PR#: | 05-2119085533-37-0000 | Molar Mass(g/mol): | 133.15 |
Storage Condition: | Store In A Tightly Closed Container. | Packaging: | 200kgs/iron Drum With Plastic Lining |
EC No: | 216-201-3 | ||
High Light: | api active pharmaceutical ingredient,pharmaceutical active ingredients |
3-methoxybenzonitrile Active Pharmaceutical Ingredients For Tapentadol 1527-89-5
Basic Information
3-methoxybenzonitrile, also known as 3-methoxy benzonitrile, m-methoxy benzonitrile, colorless or slightly yellow liquid.
Name | 3-methoxybenzontrile |
Synonym | m-Anisonitrile; AKOS B004087; 3-ANISONITRILE; 3-METHOXYBENZONITRILE; 3-CYANOANISOLE; M-METHOXYBENZONITRILE; Benzonitrile, 3-methoxy-; Benzonitrile, m-methoxy- |
CAS No | 1527-89-5 |
EC No | 216-201-3 |
Molecular formula | C8H7NO |
Molar mass (g/mol) |
133.15 |
Reach PR# |
05-2119085533-37-0000 |
Density | 1.089 g/mL at 25 °C |
Melting point | |
Boling point | 111.0~112.0ºC(13mmHg) |
Solubility |
Specifications
P/N# : MBN.99P.N
Grade : Pharmaceutical grade
Purity : ≥99.0%
Melting range :
Water :
Quality standard : meets company specification
Hazards Identification
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.
Application
Used as a pharmaceutical intermediate, it is an important intermediate of the new antipyretic analgesic - tapentadol. The drug is mainly used to relieve moderate and severe acute pain, especially for the relief of adults over 18 years of age. Its quick release tablets were approved by the US Food and Drug Administration (trade name: NUCNTA) in November 2008 to relieve moderate and severe acute pain;Its sustained-release tablets were approved for marketing in August 2012 (trade name: NUCYNTA ER) for the treatment of adult diabetic neuropathy (DPN) -related neuropathic pain.In addition, it also can participate in a variety of organic synthesis.
Storage condition
Store in a cool, dry place, avoid direct sunlight. Store in a tightly closed container.
Safety term
Wear appropriate protective clothing and gloves.
Avoid contact with skin and eyes.
Competitive Advantage
BeiLi is a professional manufacturer of MBN 3-methoxybenzonitrile CAS 1527-89-5 . 1) We can provide costomers with "one-stop"packaging service,from research,development,production,export and so on. 2) Powerful R&D strength let our technology in a leading level,forever,in turn,to provide customers with better service . 3) We have ISO certificate which let the customers more satisfied and rest assured. 4) More than 20 years of export experience,we can provide customers with more professional service.
More importantly , Headquartered in Lianyungang which is an international port city, one of China's top ten seaports. At the same time, the company has a branch in Shanghai. Shanghai, is one of the world's largest port, convenient for the customes provide logistics services.
Contact Person: lick